# Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Setting

> **NCT05153603** · — · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 50 (estimated)

## Conditions studied

- Ovarian Neoplasms

## Interventions

- **DRUG:** Olaparib mono-maintenance therapy

## Key facts

- **NCT ID:** NCT05153603
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04
- **Primary completion:** 2022-09
- **Final completion:** 2022-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05153603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05153603, "Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Setting". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05153603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*